A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial

Michael P Schaub, Andreas Wenger, Oliver Berg, Thilo Beck, Lars Stark, Eveline Buehler, Severin Haug, Michael P Schaub, Andreas Wenger, Oliver Berg, Thilo Beck, Lars Stark, Eveline Buehler, Severin Haug

Abstract

Background: After alcohol and tobacco, cannabis is the most widely used psychoactive substance in many countries worldwide. Although approximately one in ten users develops serious problems of dependency, only a minority attend outpatient addiction counseling centers. A Web-based intervention could potentially reach those users who hesitate to approach such treatment centers.

Objective: To test the efficacy of a Web-based self-help intervention with and without chat counseling-Can Reduce-in reducing the cannabis use of problematic cannabis users as an alternative to outpatient treatment services.

Methods: Altogether, 436 participants were recruited by various online and offline media for the Web-based trial. A total of 308 of these were eligible for study participation and were randomly allocated in an unblinded manner to either self-help with chat (n=114), self-help without chat (n=101), or a waiting list control group (n=93). The fully automated self-help intervention consisted of eight modules designed to reduce cannabis use, and was based on the principles of motivational interviewing, self-control practices, and methods of cognitive behavioral therapy. Additional individual chat counseling sessions were based on the same therapeutic principles. The sessions were conducted by trained counselors and addressed participants' personal problems. The main outcomes were the frequency (number of days) and quantity of cannabis use (number of standardized joints) per week, as entered into the consumption diary at baseline and at the 3-month follow-up. Secondary outcomes included self-reported symptoms of cannabis use disorder, severity of cannabis dependence, risky alcohol use, and mental health symptoms. Intervention participation and retention were extracted from the user progress data and the consumption diary, respectively.

Results: Can Reduce participants were older (U=2.296, P=.02) and reported a greater number of cannabis use days at baseline than patients who entered outpatient treatment with cannabis as their main problem substance (data from the Swiss treatment demand monitoring statistics were used; chi-square [df 2]=4.0, P=.046). Participants in the self-help with chat study arm completed a mean of 3.2 modules and 27 out of 114 (23.7%) of the participants received at least one chat session. Participants in the self-help without chat study arm completed similar numbers of self-help modules. A total of 117 of 308 participants (38.0%) completed the 3-month follow-up assessment. The change in the mean number of cannabis use days per week at 3 months differed between self-help without chat (mean change 0.7, SD -0.2) and self-help with chat (mean change 1.4, SD -0.5; beta=-0.75, SE=0.32, t=-2.39, P=.02, d=0.34, 95% CI 0.07-0.61), as well as between self-help with chat and waiting list (mean change 1.0, SD -0.8; beta=0.70, SE=0.32, t=2.16, P=.03, d=0.20, 95% CI -0.07 to 0.47). However, there were no differences between self-help without chat and waiting list (beta=-0.05, SE=0.33, t=-0.16, P=.87, d=-0.14, 95% CI -0.43 to 0.14). Self-reported abstinence was significantly different in the self-help without chat study arm (2.0%) than in the self-help with chat study arm (8.8%; beta=-1.56, SE=0.79, P=.05, odds ratio [OR]=0.21, 95% CI 0.02-2.33). There were no significant differences between the study arms with respect to the secondary outcomes.

Conclusions: Web-based self-help interventions supplemented by brief chat counseling are an effective alternative to face-to-face treatment and can reach a group of cannabis users who differ in their use and sociodemographic characteristics from those who enter outpatient addiction treatment.

Trial registration: International Standard Randomized Controlled Trial Number (ISRCTN): 59948178; http://www.isrctn.com/ISRCTN59948178 (Archived by WebCite at http://www.webcitation.org/6bt01gfIr).

Keywords: Internet; Web based; behavioral self-management; cannabis; chat; cognitive behavioral therapy; counseling; motivational interviewing; self-control; self-help.

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Screenshot of the Can Reduce Web-based intervention, showing the decision on the standard cannabis joint prior to the first consumption diary entry.
Figure 2
Figure 2
Main menu of the Can Reduce Web-based intervention's study arm 1 with self-help plus chat counseling that took place within the website in a small box at the bottom right corner.
Figure 3
Figure 3
CONSORT-EHEALTH trial flowchart: overview of the participant flow for this trial.
Figure 4
Figure 4
Module completion rate for study arms 1 (self-help with chat) and 2 (self-help without chat).
Figure 5
Figure 5
Study retention based on the weekly completion of the consumption diary for study arms 1 (self-help with chat) and 2 (self-help without chat) between baseline and week 6, including 3-month follow-up completion rate.
Figure 6
Figure 6
Cannabis use days per week according to the consumption diary between baseline and 3-month follow-up for all three study arms based on the nonimputed dataset.
Figure 7
Figure 7
Weekly quantity of cannabis used in number of standardized cannabis joints between baseline and 3-month follow-up for all three study arms based on the nonimputed dataset.

References

    1. Schaub MP, Haug S, Wenger A, Berg O, Sullivan R, Beck T, Stark L. Can reduce--the effects of chat-counseling and web-based self-help, web-based self-help alone and a waiting list control program on cannabis use in problematic cannabis users: a randomized controlled trial. BMC Psychiatry. 2013;13:305. doi: 10.1186/1471-244X-13-305.
    1. Thanki D, Matias J, Griffiths P, Noor A, Olszewski D, Simon R, Vincente J. Prevalence of Daily Cannabis Use in the European Union and Norway. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction; 2013. [2015-06-25]. .
    1. Gmel G, Kuendig H, Notari L, Gmel C. Suchtmonitoring Schweiz - Konsum von Alkohol, Tabak und illegalen Drogen in der Schweiz im Jahr. Lausanne, Switzerland: Sucht Schweiz; 2014. [2015-06-25]. .
    1. Fischer B, Jeffries V, Hall W, Room R, Goldner E, Rehm J. Lower Risk Cannabis Use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health. 2011;102(5):324–327.
    1. Anthony JC. The epidemiology of cannabis dependence. In: Roffman RA, Stephens RS, editors. Cannabis Dependence: Its Nature, Consequences, Treatment. Cambridge, UK: Cambridge University Press; 2006. pp. 58–105.
    1. Fischer R, Clair C, Studer J, Cornuz J, Gmel G. Prevalence and factors associated with use of smokeless tobacco in young Swiss men. Eur J Public Health. 2014 Jun;24(3):459–464. doi: 10.1093/eurpub/ckt086.
    1. act-info . Jahresbericht 2013: Suchtberatung und Suchtbehandlung in der Schweiz. Ergebnisse des Monitoringsystems. Berne, Switzerland: Federal Office of Public Health; 2015. .
    1. act-info . Jahresbericht 2011: Suchtberatung und Suchtbehandlung in der Schweiz. Ergebnisse des Monitoringsystems. Berne, Switzerland: Federal Office of Public Health; 2012.
    1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Treatment of Cannabis-Related Disorders in Europe. Luxembourg City, Luxembourg: Publications Office of the European Union; 2015. [2015-06-25]. .
    1. Becker J, Hungerbuehler I, Berg O, Szamrovicz M, Haubensack A, Kormann A, Schaub MP. Development of an integrative cessation program for co-smokers of cigarettes and cannabis: demand analysis, program description, and acceptability. Subst Abuse Treat Prev Policy. 2013;8:33. doi: 10.1186/1747-597X-8-33.
    1. Curry SJ. eHealth research and healthcare delivery beyond intervention effectiveness. Am J Prev Med. 2007 May;32(5 Suppl):S127–S130. doi: 10.1016/j.amepre.2007.01.026.
    1. Tossmann H, Jonas B, Tensil M, Lang P, Strüber E. A controlled trial of an internet-based intervention program for cannabis users. Cyberpsychol Behav Soc Netw. 2011 Nov;14(11):673–679. doi: 10.1089/cyber.2010.0506.
    1. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: Guilford Press; 1991.
    1. Jonas B, Tossmann P, Tensil M, Leuschner F, Strüber E. Effekte einer einmaligen chat-intervention auf problematischen substanzkonsum. Sucht. 2012 Jun;58(3):173–182. doi: 10.1024/0939-5911.a000182.
    1. Rooke S, Copeland J, Norberg M, Hine D, McCambridge J. Effectiveness of a self-guided Web-based cannabis treatment program: randomized controlled trial. J Med Internet Res. 2013;15(2):e26. doi: 10.2196/jmir.2256.
    1. Goldstein MG, Niaura R, Follick MJ, Abrams DB. Effects of behavioral skills training and schedule of nicotine gum administration on smoking cessation. Am J Psychiatry. 1989 Jan;146(1):56–60.
    1. Steinberg KL, Roffman R, Carroll K, McRee B, Babor T, Miller M, Kadden R, Duresky D, Stephens R. Brief Counseling for Marijuana Dependence: A Manual for Treating Adults. Rockville, MD: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, US Department of Health and Human Services; 2005. [2015-10-06]. .
    1. Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat. 2001 Sep;21(2):55–64; discussion 65.
    1. Blankers M, Koeter MW, Schippers GM. Internet therapy versus internet self-help versus no treatment for problematic alcohol use: a randomized controlled trial. J Consult Clin Psychol. 2011 Jun;79(3):330–341. doi: 10.1037/a0023498.
    1. Can Reduce. [2015-09-29].
    1. Schaub M, Sullivan R, Stark L. Snow control - an RCT protocol for a Web-based self-help therapy to reduce cocaine consumption in problematic cocaine users. BMC Psychiatry. 2011;11:153. doi: 10.1186/1471-244X-11-153.
    1. Schaub M, Sullivan R, Haug S, Stark L. Web-based cognitive behavioral self-help intervention to reduce cocaine consumption in problematic cocaine users: randomized controlled trial. J Med Internet Res. 2012;14(6):e166. doi: 10.2196/jmir.2244.
    1. Drugs Meter. [2015-09-30].
    1. Becker J, Haug S, Kraemer T, Schaub MP. Feasibility of a group cessation program for co-smokers of cannabis and tobacco. Drug Alcohol Rev 2015. 2015;34(4):418–426.
    1. Karschner EL, Darwin WD, McMahon RP, Liu F, Wright S, Goodwin RS, Huestis MA. Subjective and physiological effects after controlled Sativex and oral THC administration. Clin Pharmacol Ther. 2011 Mar;89(3):400–407. doi: 10.1038/clpt.2010.318.
    1. Schaub M, Stohler R. Swiss Medical Forum. 2006. [2015-06-25]. Long-term adverse effects of cannabis - an underestimated problem? .
    1. Schaub MP, Uchtenhagen A. Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction. Eur Addict Res. 2013;19(6):314–324. doi: 10.1159/000350740.
    1. Schaub M, Wenger A, Bachmann A, Stark L, Haug S. Quality assurance in the guided Internet-based addiction aid as exemplified by the Swiss addiction portal Safe Zone. Suchtmedizin Forsch und Prax. 2004;16(4):187–193.
    1. Eysenbach G. CONSORT-EHEALTH: implementation of a checklist for authors and editors to improve reporting of Web-based and mobile randomized controlled trials. Stud Health Technol Inform. 2013;192:657–661.
    1. Annaheim B, Scotto TJ, Gmel G. Revising the Cannabis Use Disorders Identification Test (CUDIT) by means of Item Response Theory. Int J Methods Psychiatr Res. 2010 Sep;19(3):142–155. doi: 10.1002/mpr.308.
    1. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption--II. Addiction. 1993 Jun;88(6):791–804.
    1. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995 May;90(5):607–614.
    1. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ. The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend. 2011 Dec 1;119(1-2):123–129. doi: 10.1016/j.drugalcdep.2011.06.003.
    1. Schnell T, Münchenhagen L, Tersudi K, Daumann J, Gouzoulis-Mayfrank E. Entwicklung und evaluation eines deutschsprachigen instruments zur erfassung von cannabis-craving (CCS-7) Zeitschrift für Klinische Psychologie und Psychotherapie. 2011 Jan;40(1):33–41. doi: 10.1026/1616-3443/a000072.
    1. Heishman SJ, Singleton EG, Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction. 2001 Jul;96(7):1023–1034. doi: 10.1080/09652140120053084.
    1. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1995;1(4):208–210. doi: 10.1159/000259089.
    1. Rumpf HJ, Meyer C, Hapke U, John U. Screening for mental health: validity of the MHI-5 using DSM-IV Axis I psychiatric disorders as gold standard. Psychiatry Res. 2001 Dec 31;105(3):243–253.
    1. Blankers M, Koeter MW, Schippers GM. Missing data approaches in eHealth research: simulation study and a tutorial for nonmathematically inclined researchers. J Med Internet Res. 2010;12(5):e54. doi: 10.2196/jmir.1448.
    1. Mohr DC, Cuijpers P, Lehman K. Supportive accountability: a model for providing human support to enhance adherence to eHealth interventions. J Med Internet Res. 2011;13(1):e30. doi: 10.2196/jmir.1602.
    1. Schaub MP, Maier LJ, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S. Evaluating the efficacy of a Web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial. BMC Psychiatry. 2015;15:156. doi: 10.1186/s12888-015-0518-6.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi